Suppr超能文献

奥美拉唑增强了 TRPM6 镁转运体在结肠中的表达。

Omeprazole enhances the colonic expression of the Mg(2+) transporter TRPM6.

机构信息

Department of Physiology, Nijmegen Centre for Molecular Life Science, Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.

出版信息

Pflugers Arch. 2013 Nov;465(11):1613-20. doi: 10.1007/s00424-013-1306-0. Epub 2013 Jun 12.

Abstract

Proton pump inhibitors (PPIs) are potent blockers of gastric acid secretion, used by millions of patients suffering from gastric acid-related complaints. Although PPIs have an excellent safety profile, an increasing number of case reports describe patients with severe hypomagnesemia due to long-term PPI use. As there is no evidence of a renal Mg²⁺ leak, PPI-induced hypomagnesemia is hypothesized to result from intestinal malabsorption of Mg²⁺. The aim of this study was to investigate the effect of PPIs on Mg ²⁺homeostasis in an in vivo mouse model. To this end, C57BL/6J mice were treated with omeprazole, under normal and low dietary Mg²⁺ availability. Omeprazole did not induce changes in serum Mg²⁺ levels (1.48 ± 0.05 and 1.54 ± 0.05 mmol/L in omeprazole-treated and control mice, respectively), urinary Mg²⁺ excretion (35 ± 3 μmol/24 h and 30 ± 4 μmol/24 h in omeprazole-treated and control mice, respectively), or fecal Mg²⁺ excretion (84 ± 4 μmol/24 h and 76 ± 4 μmol/24 h in omeprazole-treated and control mice, respectively) under any of the tested experimental conditions. However, omeprazole treatment did increase the mRNA expression level of the transient receptor potential melastatin 6 (TRPM6), the predominant intestinal Mg²⁺ channel, in the colon (167 ± 15 and 100 ± 7 % in omeprazole-treated and control mice, respectively, P < 0.05). In addition, the expression of the colonic H⁺,K⁺-ATPase (cHK-α), a homolog of the gastric H⁺,K⁺-ATPase that is the primary target of omeprazole, was also significantly increased (354 ± 43 and 100 ± 24 % in omeprazole-treated and control mice, respectively, P < 0.05). The expression levels of other magnesiotropic genes remained unchanged. Based on these findings, we hypothesize that omeprazole inhibits cHK-α activity, resulting in reduced extrusion of protons into the large intestine. Since TRPM6-mediated Mg²⁺absorption is stimulated by extracellular protons, this would diminish the rate of intestinal Mg²⁺ absorption. The increase of TRPM6 expression in the colon may compensate for the reduced TRPM6 currents, thereby normalizing intestinal Mg²⁺ absorption during omeprazole treatment in C57BL/6J mice, explaining unchanged serum, urine, and fecal Mg²⁺ levels.

摘要

质子泵抑制剂(PPIs)是一种强效的胃酸分泌抑制剂,被数百万患有胃酸相关疾病的患者使用。尽管 PPIs 具有出色的安全性,但越来越多的病例报告描述了长期使用 PPI 导致严重低镁血症的患者。由于没有证据表明存在肾脏 Mg²⁺渗漏,因此 PPI 诱导的低镁血症被认为是由于肠道对 Mg²⁺的吸收不良所致。本研究旨在研究 PPI 在体内小鼠模型中对 Mg ²⁺稳态的影响。为此,将 C57BL/6J 小鼠用奥美拉唑处理,在正常和低膳食 Mg²⁺供应下进行。奥美拉唑治疗并未引起血清 Mg²⁺水平的变化(奥美拉唑治疗组和对照组分别为 1.48±0.05 和 1.54±0.05 mmol/L),尿 Mg²⁺排泄(奥美拉唑治疗组和对照组分别为 35±3 μmol/24 h 和 30±4 μmol/24 h),或粪便 Mg²⁺排泄(奥美拉唑治疗组和对照组分别为 84±4 μmol/24 h 和 76±4 μmol/24 h)。然而,奥美拉唑治疗确实增加了结肠中转录因子 melastatin 6(TRPM6)的 mRNA 表达水平,TRPM6 是肠道中主要的 Mg²⁺通道(奥美拉唑治疗组和对照组分别为 167±15%和 100±7%,P<0.05)。此外,结肠 H ⁺ ,K ⁺ -ATPase(cHK-α)的表达也显著增加,cHK-α 是奥美拉唑的主要靶标,与胃 H ⁺ ,K ⁺ -ATPase 具有同源性(奥美拉唑治疗组和对照组分别为 354±43%和 100±24%,P<0.05)。其他调节镁稳态的基因表达水平保持不变。基于这些发现,我们假设奥美拉唑抑制 cHK-α 的活性,导致质子向大肠的排出减少。由于 TRPM6 介导的 Mg²⁺吸收受到细胞外质子的刺激,这将降低肠道 Mg²⁺吸收的速率。结肠中 TRPM6 表达的增加可能补偿了减少的 TRPM6 电流,从而在 C57BL/6J 小鼠中正常化奥美拉唑治疗期间的肠道 Mg²⁺吸收,解释了血清、尿液和粪便中 Mg²⁺水平不变的原因。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验